LAURUS LABS
Sector : Pharmaceuticals and health care | Largecap | BSE
Here's the live share price of Laurus Labs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.16₹ 20.65
As on Nov 3, 2025, 4:01 PM IST
Laurus Labs Price Performance
Today's LowToday's High
₹956.00₹979.50
₹975.15
52 Weeks' Low52 Weeks' High
₹474.25₹972.60
₹975.15
Open Price
₹959.10
Prev. Close
₹954.50
Volume
80,237
Over the last 5 years, the share price of Laurus Labs has gained 26.52% CAGR. Over the past year, the corresponding return has been 95.23%.
Laurus Labs’s current P/E of 76.97x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Large cap stocks Screener.
Laurus Labs Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Laurus Labs | 5.39 | 11.82 | 14.99 | 57.19 | 95.23 | 27.49 | 26.52 |
| Sun Pharmaceutical Industries | 0.21 | 4.09 | 4.55 | -6.87 | -8.37 | 18.13 | 29.41 |
| Divi's Laboratories | 3.01 | 18.83 | 6.72 | 11.24 | 15.00 | 20.95 | 17.36 |
| Torrent Pharmaceuticals | 1.13 | 1.56 | -1.51 | 11.14 | 12.82 | 28.97 | 23.26 |
| Cipla | -4.56 | -0.15 | 0.69 | -0.92 | -3.05 | 8.78 | 15.02 |
| Dr. Reddy's Laboratories | -6.82 | -4.00 | -1.90 | 1.15 | -4.93 | 9.63 | 4.26 |
| Mankind Pharma | -1.10 | -1.38 | -6.14 | 0.97 | -10.61 | 19.09 | 11.05 |
| Zydus Lifesciences | -2.48 | -1.11 | 3.35 | 10.76 | -2.32 | 31.30 | 19.05 |
| Lupin | 2.82 | 0.21 | 6.45 | -3.50 | -9.66 | 41.03 | 16.84 |
| Alkem Laboratories | 1.43 | 3.02 | 14.92 | 10.89 | -3.15 | 20.35 | 16.18 |
| Aurobindo Pharma | 6.46 | 6.27 | 7.00 | -4.69 | -17.55 | 28.09 | 8.74 |
| Abbott India | -2.87 | -2.64 | -13.64 | -5.43 | -0.77 | 13.95 | 13.40 |
| Glenmark Pharmaceuticals | 4.15 | -3.30 | -8.37 | 37.68 | 12.01 | 66.11 | 31.97 |
| Biocon | 5.25 | 9.09 | -1.29 | 18.63 | 18.91 | 11.88 | -1.32 |
| GlaxoSmithKline Pharmaceuticals | -2.38 | -0.36 | -8.49 | -5.88 | -1.64 | 24.87 | 13.76 |
| Anthem Biosciences | -2.34 | -8.90 | -4.74 | -3.74 | -3.74 | -1.26 | -0.76 |
| Ipca Laboratories | 3.31 | -1.35 | -9.79 | -4.97 | -18.56 | 12.27 | 2.64 |
| Gland Pharma | 1.53 | -0.57 | -0.50 | 40.19 | 19.72 | 3.29 | 1.58 |
| Ajanta Pharma | 5.14 | 5.79 | -5.82 | -1.81 | -17.59 | 24.26 | 19.30 |
| Cohance Lifesciences | -15.25 | -14.55 | -24.16 | -34.53 | -44.04 | 22.21 | 19.91 |
Over the last one year, Laurus Labs has gained 95.23% compared to peers like Sun Pharmaceutical Industries (-8.37%), Divi's Laboratories (15.00%), Torrent Pharmaceuticals (12.82%). From a 5 year perspective, Laurus Labs has outperformed peers relative to Sun Pharmaceutical Industries (29.41%) and Divi's Laboratories (17.36%).
Laurus Labs Financials
Laurus Labs Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 957.25 | 953.85 |
| 10 | 939.25 | 938.84 |
| 20 | 904.45 | 918.64 |
| 50 | 891.44 | 886.86 |
| 100 | 836.54 | 833.12 |
| 200 | 714.79 | 745.5 |
Laurus Labs Share Holding Pattern
In the latest quarter, Laurus Labs saw a drop in promoter holding to 27.59%, while DII stake decreased to 11.72%, FII holding rose to 26.17%, and public shareholding moved up to 34.52% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Laurus Labs Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 59,77,891 | 1.23 | 503.22 | |
| 53,92,600 | 1.33 | 453.95 | |
| 44,68,387 | 1.45 | 376.15 | |
| 21,17,487 | 0.69 | 178.25 | |
| 20,03,815 | 2.95 | 168.68 | |
| 14,00,000 | 3 | 117.85 | |
| 10,17,010 | 0.54 | 85.61 | |
| 7,50,748 | 2.29 | 63.2 | |
| 7,48,841 | 0.38 | 63.04 | |
| 5,69,302 | 0.53 | 47.92 |
* Excluding Index & Arbitrage Funds
Laurus Labs Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Laurus Labs Options
Laurus Labs Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 28, 2025, 10:03 PM IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| Oct 24, 2025, 2:50 AM IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| Oct 23, 2025, 8:33 PM IST | Laurus Labs - Financial Results For The Quarter And Half Year Ended September 30, 2025 |
| Oct 09, 2025, 8:34 PM IST | Laurus Labs - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 09, 2025, 8:15 PM IST | Laurus Labs - Board Meeting Intimation for Inter-Alia To Consider The Un-Audited Financial Results Of The Company For The Qua |
About Laurus Labs
Laurus Labs Ltd. is a Public Limited Listed company incorporated on 19/09/2005 and has its registered office in the State of Andhra Pradesh, India. Company's Corporate Identification Number(CIN) is L24239AP2005PLC047518 and registration number is 047518. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 5216.98 Cr. and Equity Capital is Rs. 107.85 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressLaurus Enclave, Plot Office 01, Edulapakabonangi Village, Vishakapatnam Andhra Pradesh 531021
- Contact
Management
- Dr. Ravindranath KancherlaNon Exe.Chairman&Ind.Director
- Mr. V V Ravi KumarExecutive Director & CFO
- Dr. Satyanarayana ChavaExecutive Director & CEO
- Ms. Soumya ChavaExecutive Director
- Dr. C V Lakshmana RaoExecutive Director
- Mr. Krishna Chaitanya ChavaExecutive Director
- Mrs. Aruna Rajendra BhingeIndependent Director
- Mr. Karnam SekarIndependent Director
- Dr. Rajesh Koshy ChandyIndependent Director
- Mr. Ramesh SubrahmanianIndependent Director
FAQs on Laurus Labs Share Price
What is the share price of Laurus Labs?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Laurus Labs is ₹975.15 as on Nov 03, 2025.
What kind of stock is Laurus Labs?
The Laurus Labs is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
What is the Market Cap of Laurus Labs?
The market cap of Laurus Labs is ₹52,641.03 Cr as on Nov 03, 2025.
What are today's High and Low prices of Laurus Labs?
Today’s highest and lowest price of Laurus Labs are ₹979.50 and ₹956.00.
What are the 52 Week High and 52 Week Low of Laurus Labs?
The 52-week high/low is the highest and lowest price at which Laurus Labs stock has traded in the past 52-week or nearly a year. The 52-week high of Laurus Labs is ₹972.60 and 52-week low of Laurus Labs is ₹474.25 as on Nov 03, 2025.
How has the Laurus Labs performed historically in terms of returns?
The Laurus Labs has shown returns of 2.16% over the past day, 11.82% for the past month, 14.99% over 3 months, 95.23% over 1 year, 27.49% across 3 years, and 26.52% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Laurus Labs?
P/E ratio of and PB ratio of Laurus Labs are 76.97 and 11.77 on Nov 03, 2025. While the company gives a dividend yield of 0.12 per annum.
Laurus Labs News
✕
Market Pulse